A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis

OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Faraaz Ali Shah, MD, MPH, Georgios D. Kitsios, MD, PhD, Sachin Yende, MD, MS, Daniel G. Dunlap, MD, Denise Scholl, CRC, Byron Chuan, MS, Nameer Al-Yousif, MD, Yingze Zhang, PhD, Seyed Mehdi Nouraie, MD, PhD, Alison Morris, MD, MS, David T. Huang, MD, MPH, Christopher P. O’Donnell, PhD, Bryan J. McVerry, MD
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ee595d7e5914568a24a492c5f3d9bb7
record_format dspace
spelling oai:doaj.org-article:7ee595d7e5914568a24a492c5f3d9bb72021-11-25T07:56:43ZA Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis2639-802810.1097/CCE.0000000000000550https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb72021-10-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000550https://doaj.org/toc/2639-8028OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early enteral dextrose infusion on systemic inflammation and glucose metabolism in critically ill septic patients. DESIGN:. Single-center, double-blind, placebo-controlled randomized pilot clinical trial (NCT03454087). SETTING:. Tertiary-care medical center in Pittsburgh, PA. PATIENTS:. Critically ill adult patients within 48 hours of sepsis diagnosis and with established enteral access. INTERVENTIONS:. Participants were randomized 1:1 to receive a continuous water (placebo) or enteral dextrose infusion (50% dextrose; 0.5 g/mL) at 10 mL per hour for 24 hours. MEASUREMENTS AND MAIN RESULTS:. We randomized 58 participants between June 2018 and January 2020 (placebo: n = 29, dextrose: n = 29). Protocol adherence was high with similar duration of study infusion in the placebo (median duration, 24 hr [interquartile range, 20.9–24 hr]) and dextrose (23.9 hr [23–24 hr]) groups (p = 0.59). The primary outcome of circulating interleukin-6 at end-infusion did not differ between the dextrose (median, 32 pg/mL [19–79 pg/mL]) and placebo groups (24 pg/mL [9–59 pg/mL]; p = 0.13) with similar results in other measures of the systemic host immune response. Enteral dextrose increased circulating glucose-dependent insulinotropic peptide (76% increase; 95% CI [35–119]; p < 0.01) and insulin (53% [17–88]; p < 0.01) compared with placebo consistent with preclinical studies, but also increased blood glucose during the 24-hour infusion period (153 mg/dL [119–223] vs 116 mg/dL [91–140]; p < 0.01). Occurrence of emesis, ICU and hospital length of stay, and 30-day mortality did not differ between the placebo and enteral dextrose groups. CONCLUSIONS:. Early infusion of low-level enteral dextrose in critically ill septic patients increased circulating levels of insulin and the incretin hormone glucose-dependent insulinotropic peptide without decreasing systemic inflammation.Faraaz Ali Shah, MD, MPHGeorgios D. Kitsios, MD, PhDSachin Yende, MD, MSDaniel G. Dunlap, MDDenise Scholl, CRCByron Chuan, MSNameer Al-Yousif, MDYingze Zhang, PhDSeyed Mehdi Nouraie, MD, PhDAlison Morris, MD, MSDavid T. Huang, MD, MPHChristopher P. O’Donnell, PhDBryan J. McVerry, MDWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 10, p e550 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Faraaz Ali Shah, MD, MPH
Georgios D. Kitsios, MD, PhD
Sachin Yende, MD, MS
Daniel G. Dunlap, MD
Denise Scholl, CRC
Byron Chuan, MS
Nameer Al-Yousif, MD
Yingze Zhang, PhD
Seyed Mehdi Nouraie, MD, PhD
Alison Morris, MD, MS
David T. Huang, MD, MPH
Christopher P. O’Donnell, PhD
Bryan J. McVerry, MD
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
description OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early enteral dextrose infusion on systemic inflammation and glucose metabolism in critically ill septic patients. DESIGN:. Single-center, double-blind, placebo-controlled randomized pilot clinical trial (NCT03454087). SETTING:. Tertiary-care medical center in Pittsburgh, PA. PATIENTS:. Critically ill adult patients within 48 hours of sepsis diagnosis and with established enteral access. INTERVENTIONS:. Participants were randomized 1:1 to receive a continuous water (placebo) or enteral dextrose infusion (50% dextrose; 0.5 g/mL) at 10 mL per hour for 24 hours. MEASUREMENTS AND MAIN RESULTS:. We randomized 58 participants between June 2018 and January 2020 (placebo: n = 29, dextrose: n = 29). Protocol adherence was high with similar duration of study infusion in the placebo (median duration, 24 hr [interquartile range, 20.9–24 hr]) and dextrose (23.9 hr [23–24 hr]) groups (p = 0.59). The primary outcome of circulating interleukin-6 at end-infusion did not differ between the dextrose (median, 32 pg/mL [19–79 pg/mL]) and placebo groups (24 pg/mL [9–59 pg/mL]; p = 0.13) with similar results in other measures of the systemic host immune response. Enteral dextrose increased circulating glucose-dependent insulinotropic peptide (76% increase; 95% CI [35–119]; p < 0.01) and insulin (53% [17–88]; p < 0.01) compared with placebo consistent with preclinical studies, but also increased blood glucose during the 24-hour infusion period (153 mg/dL [119–223] vs 116 mg/dL [91–140]; p < 0.01). Occurrence of emesis, ICU and hospital length of stay, and 30-day mortality did not differ between the placebo and enteral dextrose groups. CONCLUSIONS:. Early infusion of low-level enteral dextrose in critically ill septic patients increased circulating levels of insulin and the incretin hormone glucose-dependent insulinotropic peptide without decreasing systemic inflammation.
format article
author Faraaz Ali Shah, MD, MPH
Georgios D. Kitsios, MD, PhD
Sachin Yende, MD, MS
Daniel G. Dunlap, MD
Denise Scholl, CRC
Byron Chuan, MS
Nameer Al-Yousif, MD
Yingze Zhang, PhD
Seyed Mehdi Nouraie, MD, PhD
Alison Morris, MD, MS
David T. Huang, MD, MPH
Christopher P. O’Donnell, PhD
Bryan J. McVerry, MD
author_facet Faraaz Ali Shah, MD, MPH
Georgios D. Kitsios, MD, PhD
Sachin Yende, MD, MS
Daniel G. Dunlap, MD
Denise Scholl, CRC
Byron Chuan, MS
Nameer Al-Yousif, MD
Yingze Zhang, PhD
Seyed Mehdi Nouraie, MD, PhD
Alison Morris, MD, MS
David T. Huang, MD, MPH
Christopher P. O’Donnell, PhD
Bryan J. McVerry, MD
author_sort Faraaz Ali Shah, MD, MPH
title A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
title_short A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
title_full A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
title_fullStr A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
title_full_unstemmed A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
title_sort pilot double-blind placebo-controlled randomized clinical trial to investigate the effects of early enteral nutrients in sepsis
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb7
work_keys_str_mv AT faraazalishahmdmph apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT georgiosdkitsiosmdphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT sachinyendemdms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT danielgdunlapmd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT deniseschollcrc apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT byronchuanms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT nameeralyousifmd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT yingzezhangphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT seyedmehdinouraiemdphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT alisonmorrismdms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT davidthuangmdmph apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT christopherpodonnellphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT bryanjmcverrymd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT faraazalishahmdmph pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT georgiosdkitsiosmdphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT sachinyendemdms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT danielgdunlapmd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT deniseschollcrc pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT byronchuanms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT nameeralyousifmd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT yingzezhangphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT seyedmehdinouraiemdphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT alisonmorrismdms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT davidthuangmdmph pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT christopherpodonnellphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
AT bryanjmcverrymd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis
_version_ 1718413628836675584